• Japanese
  • Korean
  • Chinese
Cover Image

Impetigo Global Clinical Trials Review, H1, 2013

Abstract

Impetigo Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, "Impetigo Global Clinical Trials Review, H1, 2013" provides data on the Impetigo clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Impetigo. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Impetigo. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

TOC

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Introduction 6
  • Impetigo 6
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials by Country 8
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by BRIC Nations 15
  • Clinical Trials by G7 Nations 16
  • Clinical Trials in G7 Nations by Trial Status 17
  • Clinical Trials by E7 Nations 18
  • Clinical Trials in E7 Nations by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Unaccomplished Trials of Impetigo 23
  • Subjects Recruited Over a Period of Time 24
  • Prominent Sponsors 25
  • Top Companies Participating in Impetigo Therapeutics Clinical Trials 27
  • Prominent Drug Comparison 29
  • Clinical Trial Profiles 30
  • Clinical Trial Overview of Top Companies 30
  • GlaxoSmithKline plc 30
  • Clinical Trial Overview of GlaxoSmithKline plc 30
  • Lytix Biopharma AS 31
  • Clinical Trial Overview of Lytix Biopharma AS 31
  • LEO Pharma A/S 32
  • Clinical Trial Overview of LEO Pharma A/S 32
  • NovaBay Pharmaceuticals, Inc. 33
  • Clinical Trial Overview of NovaBay Pharmaceuticals, Inc. 33
  • Ferrer Internacional S.A. 34
  • Clinical Trial Overview of Ferrer Internacional S.A. 34
  • Foamix Ltd. 35
  • Clinical Trial Overview of Foamix Ltd. 35
  • Interdos Pharma bv 36
  • Clinical Trial Overview of Interdos Pharma bv 36
  • Ambria Dermatology AB (Inactive) 37
  • Clinical Trial Overview of Ambria Dermatology AB (Inactive) 37
  • InfectoPharm Arzneimittel und Consilium GmbH 38
  • Clinical Trial Overview of InfectoPharm Arzneimittel und Consilium GmbH 38
  • GlaxoSmithKline Inc. 39
  • Clinical Trial Overview of GlaxoSmithKline Inc. 39
  • Galderma S.A. 40
  • Clinical Trial Overview of Galderma S.A. 40
  • Stiefel Laboratories, Inc. 41
  • Clinical Trial Overview of Stiefel Laboratories, Inc. 41
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals 42
  • Menzies School of Health Research 42
  • Clinical Trial Overview of Menzies School of Health Research 42
  • Royal North Shore Hospital 43
  • Clinical Trial Overview of Royal North Shore Hospital 43
  • The University of Texas Health Science Center at Houston 44
  • Clinical Trial Overview of The University of Texas Health Science Center at Houston 44
  • Five Key Clinical Profiles 45

Appendix 80

  • Abbreviations 80
  • Definitions 80
  • Research Methodology 81
  • Secondary Research 81
  • About GlobalData 82
  • Contact Us 82
  • Disclaimer 82
  • Source 83

List of Tables

List of Tables

  • Impetigo Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
  • Impetigo Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
  • Impetigo Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
  • Impetigo Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 10
  • Impetigo Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
  • Impetigo Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
  • Impetigo Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
  • Impetigo Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 14
  • Impetigo Therapeutics Clinical Trials, BRIC Countries, 2013* 15
  • Impetigo Therapeutics Clinical Trials, G7 Countries, 2013* 16
  • Impetigo Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
  • Impetigo Therapeutics Clinical Trials, E7 Countries, 2013* 18
  • Impetigo Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
  • Impetigo Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
  • Impetigo Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
  • Impetigo Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
  • Impetigo Therapeutics Market, Global, Terminated Clinical Trials, 2013* 23
  • Impetigo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24
  • Impetigo Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
  • Impetigo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 28
  • Impetigo Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 30
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Lytix Biopharma AS, 2013* 31
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by LEO Pharma A/S, 2013* 32
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by NovaBay Pharmaceuticals, Inc., 2013* 33
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferrer Internacional S.A., 2013* 34
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Foamix Ltd., 2013* 35
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Interdos Pharma bv, 2013* 36
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Ambria Dermatology AB (Inactive), 2013* 37
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by InfectoPharm Arzneimittel und Consilium GmbH, 2013* 38
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Inc., 2013* 39
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Galderma S.A., 2013* 40
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Stiefel Laboratories, Inc., 2013* 41
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Menzies School of Health Research, 2013* 42
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal North Shore Hospital, 2013* 43
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2013* 44

List of Figures

List of Figures

  • Impetigo Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
  • Impetigo Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
  • Impetigo Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
  • Impetigo Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 10
  • Impetigo Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
  • Impetigo Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
  • Impetigo Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
  • Impetigo Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 14
  • Impetigo Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
  • Impetigo Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
  • Impetigo Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
  • Impetigo Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
  • Impetigo Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
  • Impetigo Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
  • Impetigo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24
  • Impetigo Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 25
  • Impetigo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 27
  • Impetigo Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29
  • GlobalData Methodology 81
Show More
Pricing
Get Notified
Email me when related reports are published